Coronavirus

Massachusetts Eye and Ear Developing Gene-based Vaccine Against SARS-CoV2

An experimental novel gene-based vaccine candidate against SARS-CoV2 is being developed and tested by Massachusetts Eye and Ear and Massachusetts General Hospital, according to a press release. The AAVCOVID vaccine program uses adeno-associated viral (AAV) vector to send genetic sequences of the SARS-CoV-2 Spike antigen to help the body develop...